Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 124.60
+1.10 (0.89%)
Oct 1, 2026, 2:24 PM IDT
Evogene Employees
Evogene had 52 employees as of December 31, 2025. The number of employees decreased by 65 or -55.56% compared to the previous year.
Employees
52
Change (1Y)
-65
Growth (1Y)
-55.56%
Revenue / Employee
94.93K ILS
Profits / Employee
-519.80K ILS
Market Cap
19.51M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 52 | -65 | -55.56% | 52 | 0 |
| Dec 31, 2024 | 117 | -25 | -17.61% | 117 | 0 |
| Dec 31, 2023 | 142 | 5 | 3.65% | 142 | 0 |
| Dec 31, 2022 | 137 | -4 | -2.84% | 137 | 0 |
| Dec 31, 2021 | 141 | 10 | 7.63% | 141 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bonus BioGroup | 42 |
| BioLineRx | 24 |
| Matricelf | 15 |
| Purple Biotech | 10 |
| Can-Fite BioPharma | 5 |
| XTL Biopharmaceuticals | 5 |
| BioLight Life Sciences | 4 |
Evogene News
- 3 days ago - Evogene receives non-compliance letter from Nasdaq - TheFly
- 3 days ago - Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance - PRNewsWire
- 4 weeks ago - Evogene responds to latest communication from L.I.A. Pure Capital, Invest-Pro - TheFly
- 4 weeks ago - Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward - PRNewsWire
- 5 weeks ago - EverGen Infrastructure Announces Voting Results for the Annual General Meeting of Shareholders Held on August 25, 2026 - Business Wire
- 5 weeks ago - Evogene (EVGN) Q2 2026 Earnings Call Transcript - The Motley Fool
- 5 weeks ago - Evogene’s director nominees recommended by ISS and Glass Lewis - TheFly
- 5 weeks ago - Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees - PRNewsWire